How to define high risk BCC and SCC?

被引：0
|
作者：
Lear, J. [1 ]
机构：
[1] Dermatol Ctr, Stott Lane, Salford, Lancs, England
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
SY20.3
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] When is the Radiation Therapy a real Alternative (BCC/SCC)?
    Koelbl, O.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 46 - 46
  • [22] How do Swedish Government agencies define risk?
    Boholm, Max
    JOURNAL OF RISK RESEARCH, 2019, 22 (06) : 717 - 734
  • [23] How to define and interpret a probability in a risk and safety setting
    Aven, Terje
    Reniers, Genserik
    SAFETY SCIENCE, 2013, 51 (01) : 223 - 231
  • [24] Differential autocrine ErbB signaling in SCC vs BCC
    Rittie, L
    Kansra, S
    Li, Y
    Stoll, SW
    Michael, LE
    Shao, Y
    Boyd, C
    Johnson, TM
    Fisher, GJ
    Elder, JT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A21 - A21
  • [25] How should we define patients who are at high risk of death from prostate cancer?
    Vickers, Andrew
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (12): : 646 - 647
  • [26] How should we define patients who are at high risk of death from prostate cancer?
    Andrew Vickers
    Nature Clinical Practice Urology, 2007, 4 : 646 - 647
  • [27] Increased risk of SCC with high-dose PUVA
    Reactions Weekly, 1999, 737 (1) : 5 - 5
  • [28] Biological Threat Detection in the Air and on the Surface: How to Define the Risk
    Trafny, Elzbieta Anna
    Lewandowski, Rafal
    Stepinska, Malgorzata
    Kaliszewski, Miron
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (04) : 253 - 261
  • [29] HOW CAN WE DEFINE A PATIENT AT IMMINENT RISK OF FRACTURE?
    Harvey, N. C.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S77 - S77
  • [30] Biological Threat Detection in the Air and on the Surface: How to Define the Risk
    Elżbieta Anna Trafny
    Rafał Lewandowski
    Małgorzata Stępińska
    Miron Kaliszewski
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 253 - 261
12345